JP2017505800A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505800A5
JP2017505800A5 JP2016551767A JP2016551767A JP2017505800A5 JP 2017505800 A5 JP2017505800 A5 JP 2017505800A5 JP 2016551767 A JP2016551767 A JP 2016551767A JP 2016551767 A JP2016551767 A JP 2016551767A JP 2017505800 A5 JP2017505800 A5 JP 2017505800A5
Authority
JP
Japan
Prior art keywords
therapeutic
acid
poly
phase
nanoparticle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016551767A
Other languages
English (en)
Japanese (ja)
Other versions
JP6573895B2 (ja
JP2017505800A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/015887 external-priority patent/WO2015123562A1/en
Publication of JP2017505800A publication Critical patent/JP2017505800A/ja
Publication of JP2017505800A5 publication Critical patent/JP2017505800A5/ja
Application granted granted Critical
Publication of JP6573895B2 publication Critical patent/JP6573895B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016551767A 2014-02-13 2015-02-13 治療剤を含む治療用ナノ粒子ならびにその製造方法および使用方法 Expired - Fee Related JP6573895B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461939363P 2014-02-13 2014-02-13
US61/939,363 2014-02-13
PCT/US2015/015887 WO2015123562A1 (en) 2014-02-13 2015-02-13 Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same

Publications (3)

Publication Number Publication Date
JP2017505800A JP2017505800A (ja) 2017-02-23
JP2017505800A5 true JP2017505800A5 (enExample) 2018-03-22
JP6573895B2 JP6573895B2 (ja) 2019-09-11

Family

ID=52595474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016551767A Expired - Fee Related JP6573895B2 (ja) 2014-02-13 2015-02-13 治療剤を含む治療用ナノ粒子ならびにその製造方法および使用方法

Country Status (11)

Country Link
US (2) US10080723B2 (enExample)
EP (1) EP3104838B1 (enExample)
JP (1) JP6573895B2 (enExample)
CA (1) CA2939261C (enExample)
DK (1) DK3104838T3 (enExample)
ES (1) ES2770733T3 (enExample)
HU (1) HUE047934T2 (enExample)
PL (1) PL3104838T3 (enExample)
PT (1) PT3104838T (enExample)
SI (1) SI3104838T1 (enExample)
WO (1) WO2015123562A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3104838T3 (da) 2014-02-13 2020-02-24 Pfizer Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf
WO2015200054A2 (en) 2014-06-24 2015-12-30 The Trustees Of Princeton University Process for encapsulating soluble biologics, therapeutics, and imaging agents
BR112018003110A2 (pt) * 2015-08-21 2018-09-25 Pfizer nanopartículas terapêuticas compreendendo um agente terapêutico e métodos de fabricação e uso dos mesmos
EP3432864B1 (en) * 2016-03-22 2020-05-06 Pfizer Inc Process for preparing therapeutic nanoparticles
WO2018208993A1 (en) * 2017-05-09 2018-11-15 Dignity Health Drug delivery composition and method of fabrication
WO2019055539A1 (en) 2017-09-12 2019-03-21 Prudhomme Robert K CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME
JP2021501753A (ja) * 2017-11-03 2021-01-21 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティThe Trustees Of Princeton University 徐放性ナノキャリア製剤を形成するための疎水性イオン対化およびフラッシュナノ沈殿
EP3784705A4 (en) * 2018-04-23 2022-03-02 Graybug Vision, Inc. IMPROVED CONTINUOUS PRODUCTION OF MICROPARTICLES
TWI787523B (zh) 2018-06-15 2022-12-21 漢達生技醫藥股份有限公司 達沙替尼十二烷基硫酸鹽之結晶
WO2020018890A1 (en) 2018-07-19 2020-01-23 Prudhomme Robert K Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents
US11731099B2 (en) 2018-07-20 2023-08-22 The Trustees Of Princeton University Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
US20260199517A1 (en) * 2022-11-18 2026-07-16 Haima Therapeutics, Llc Lyophilization buffers for peptide-decorated liposomes
KR20250136810A (ko) 2023-01-31 2025-09-16 한다 온콜로지, 엘엘씨 개선된 카보잔티닙 조성물 및 사용 방법
US20260108582A1 (en) * 2024-10-23 2026-04-23 Finitus, LLC Compositions and methods for intranasal delivery of carnosine for treatment of neurodegenerative diseases and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869884B2 (en) * 2002-08-22 2005-03-22 Chartered Semiconductor Manufacturing Ltd. Process to reduce substrate effects by forming channels under inductor devices and around analog blocks
AU2004259209A1 (en) * 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
AU2009268923B2 (en) 2008-06-16 2015-09-17 Pfizer Inc. Drug loaded polymeric nanoparticles and methods of making and using same
BR112015005878A2 (pt) * 2012-09-17 2017-07-04 Bind Therapeutics Inc nanopartículas terapêuticas compreendendo agente terapêutico e métodos de preparar e usar as mesmas
HUE043998T2 (hu) 2012-09-17 2019-09-30 Pfizer Eljárás terápiás nanorészecskék elõállítására
HUE034490T2 (en) * 2013-09-16 2018-02-28 Astrazeneca Ab Therapeutic polymer nanoparticles and methods for their preparation and use
DK3104838T3 (da) 2014-02-13 2020-02-24 Pfizer Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf
EP3116547B1 (en) 2014-03-14 2019-06-05 Pfizer Inc Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same

Similar Documents

Publication Publication Date Title
Pan et al. Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy
HRP20191187T1 (hr) Terapijske nanočestice koje sadrže terapijsko sredstvo, te postupci njihove proizvodnje i upotrebe
Ardeshirzadeh et al. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds
Harrisson et al. Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization
Bilensoy et al. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors
Limiti et al. Hyaluronic acid–polyethyleneimine nanogels for controlled drug delivery in cancer treatment
JP2017508803A5 (enExample)
CA2922279C (en) Therapeutic polymeric nanoparticles and methods of making and using same
CN107106496B (zh) 聚合物纳米粒子冷冻干燥物及其制备方法
JP6573895B2 (ja) 治療剤を含む治療用ナノ粒子ならびにその製造方法および使用方法
RU2016149734A (ru) Направленно доставляемые терапевтические наночастицы и способы их получения и использования
Ji et al. Preparation, evaluation, and in vitro release of folic acid conjugated O‐carboxymethyl chitosan nanoparticles loaded with methotrexate
CN103764172A (zh) 控释系统
JP2012522055A5 (enExample)
Al-Roujayee et al. Alginate-based systems: advancements in drug delivery and wound healing
JP2011519932A5 (enExample)
RU2018115566A (ru) Терапевтические наночастицы, содержащие терапевтический агент, и их способы получения и применения
CN114144187A (zh) 含有药物药剂和/或营养药剂的脂质纳米颗粒及其方法
Bei et al. Novel self-assembled micelles based on palmitoyl-trimethyl-chitosan for efficient delivery of harmine to liver cancer
Ramasamy et al. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis
Albisa et al. Polymeric nanomaterials as nanomembrane entities for biomolecule and drug delivery
CN103006572B (zh) 一种pH敏感性萝卜硫素壳聚糖微球的制备方法
EP3119395B1 (en) Polymeric nanoparticles and methods of making and using same
TW201625317A (zh) 喜樹鹼類高分子衍生物之醫藥製劑
TWI595895B (zh) 用於癌症治療之16-羥基克羅烷-3,13-二烯-15,16-內酯製劑